DELAYED ONSET OF TREATMENT IN A PATIENT WITH ULCERATIVE COLITIS: A CASE OF HOW DISPARITIES AFFECT HEALTHCARE ACCESS.

被引：0
|
作者：
Ibarra, Maria
Guzman, Adalberto
Ravichander, Benjamin
Sangha, Lillian
Mishagina, Irina
机构：
来源：
INFLAMMATORY BOWEL DISEASES | 2023年 / 29卷
关键词：
D O I：
10.1093/ibd/izac247.077
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S42 / S43
页数：3
相关论文
共 36 条
  • [21] Treatment-Naive Ulcerative Colitis Patient Treated With Lyophilized Full Spectrum Microbiota: A Case Study
    De Zoysa, Prathibha
    Kingston-Smith, Harriet
    Maistry, Priya
    Jayewardene, Avindra F.
    Borody, Thomas J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S1095 - S1096
  • [22] A case report of mesalazine-induced pulmonary brosis in a patient with hemorrhagic ulcerative colitis: imputability and original treatment
    Gering, Audrey
    Bourget, Stephanie
    Saurel, Nathalie
    Villier, Celine
    Allenet, Benoit
    Mallaret, Michel
    PHARMACY WORLD & SCIENCE, 2007, 29 (05): : 457 - 457
  • [23] Healthcare Access Domains Mediate Racial Disparities in Ovarian Cancer Treatment Quality in a US Patient Cohort: A Structural Equation Modelling Analysis
    Akinyemiju, Tomi
    Chen, Quan
    Wilson, Lauren E.
    Previs, Rebecca A.
    Joshi, Ashwini
    Liang, Margaret
    Pisu, Maria
    Ward, Kevin C.
    Berchuck, Andrew
    Schymura, Maria J.
    Huang, Bin
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2023, 32 (01) : 74 - 81
  • [24] Case Report: Onset of Type 1 Diabetes Mellitus in a Patient With Ulcerative Colitis and Sjogren's Syndrome Under Euthyroid Hashimoto's Thyroiditis
    Takahashi, Kaio
    Anno, Takatoshi
    Matsuda, Akio
    Kimura, Yukiko
    Kawasaki, Fumiko
    Kaku, Kohei
    Tomoda, Koichi
    Kawamoto, Hirofumi
    Kaneto, Hideaki
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [25] The relationship among multiple patient-reported outcomes measures for patients with ulcerative colitis receiving treatment with MMX® formulated delayed-release mesalamine
    Aaron Yarlas
    Linnette Yen
    Paul Hodgkins
    Quality of Life Research, 2015, 24 : 671 - 683
  • [26] The relationship among multiple patient-reported outcomes measures for patients with ulcerative colitis receiving treatment with MMXA® formulated delayed-release mesalamine
    Yarlas, Aaron
    Yen, Linnette
    Hodgkins, Paul
    QUALITY OF LIFE RESEARCH, 2015, 24 (03) : 671 - 683
  • [27] Diffuse febrile dermatosis in a patient with active ulcerative colitis under treatment with steroids and azathioprine: a case of Sweet's syndrome - Case report and review of literature
    Paoluzi, OA
    Crispino, P
    Amantea, A
    Pica, R
    Iacopini, F
    Consolazio, A
    Di Palma, V
    Rivera, M
    Paoluzi, P
    DIGESTIVE AND LIVER DISEASE, 2004, 36 (05) : 361 - 366
  • [28] Epstein–Barr virus-associated hemophagocytic syndrome in a patient with ulcerative colitis during treatment with azathioprine: A case report and review of literature
    Kazuya Miyaguchi
    Minoru Yamaoka
    Yoshikazu Tsuzuki
    Keigo Ashitani
    Hideki Ohgo
    Yoshitaka Miyagawa
    Keisuke Ishizawa
    Hidekazu Kayano
    Hidetomo Nakamoto
    Hiroyuki Imaeda
    World Journal of Clinical Cases, 2018, (14) : 776 - 780
  • [29] Changes in circulating levels of HIV, CD4, and tissue expression of HIV in a patient with recent-onset ulcerative colitis treated by surgery -: Case report
    Silver, S
    Wahl, SM
    Orkin, BA
    Orenstein, JM
    JOURNAL OF HUMAN VIROLOGY, 1999, 2 (01) : 52 - 57
  • [30] Consensus recommendations for patient-centered therapy in mild-to-moderate ulcerative colitis: the i Support Therapy-Access to Rapid Treatment (iSTART approach
    Danese, Silvio
    Banerjee, Rupa
    Cummings, J. R. Fraser
    Dotan, Iris
    Kotze, Paulo G.
    Leong, Rupert Wing Lonng
    Paridaens, Kristine
    Peyrin-Biroulet, Laurent
    Scott, Glyn
    Van Assche, Gert
    Wehkamp, Jan
    Yamamoto-Furusho, Jesus K.
    INTESTINAL RESEARCH, 2018, 16 (04) : 522 - +
1234